Vimarsana
Biggest News Aggregation in the World

Page 2 - Aggressive Lymphomas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aggressive Lymphomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aggressive Lymphomas Today - Breaking & Trending Today

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition - Vimarsana News

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition

Published: November 4, 2021

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Source: prnewswire.com
Related Topics:
United StatesEltanexor MonotherapyPraneeth SudalaguntaSuresh Kumar BalasubramanianH Lee MoffittYuki NishidaMarie MaerevoetSrinivas TantravahiDarrell WhiteSuzanne LentzschWaldenstrom MacroglobulinemiaJatin ShahSangmin LeePiroska KlementPaula RodrSundar JagannathPaula RestrepoMuhamed BaljevicYael CohenNizar BahlisSelective Inhibitor Of Nuclear ExportColumbia University Irving Medical CenterCompany To Host Investor Day EventMount Sinai School Of MedicineJules Bordet Institute
Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting - Vimarsana News

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

Published: June 18, 2021

Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.

Source: news-medical.net
Related Topics:
United StatesMark LeeDavid KurtzEmily HendersonInternational Conference On Malignant LymphomaAmerican Society Of Clinical OncologyStanford UniversityInternational ConferenceMalignant LymphomaForesight DiagnosticAggressive LymphomasPhased Variant EnrichmentDetection SequencingForesight Board Member Mark LeeGlobal HeadPersonalized HealthcareClinical Oncologyஒன்றுபட்டது மாநிலங்களில்குறி லீடேவிட் கர்ட்ஸ்எமிலி ஹென்டர்சன்சர்வதேச மாநாடு ஆன் வீரியம் மிக்கது லிம்போமாஅமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல்ஸ்டான்போர்ட் பல்கலைக்கழகம்சர்வதேச மாநாடு